FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

4564811000001108: Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1963151000001116 Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1963161000001118 Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
26711901000001112 Rapamune 2mg tablets (Wyeth Laboratories) 30 tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26712001000001116 Rapamune 2mg tablets (Wyeth Laboratories) 30 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38435101000001118 Rapamune 2mg tablets (Wyeth Pharmaceuticals) 30 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
59581201000001117 Rapamune 2mg tablets (Pfizer Ltd) 30 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Is a Sirolimus 2mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Is pack of Rapamune 2mg tablets (Wyeth Laboratories) false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has active ingredient Sirolimus false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has AMP Rapamune 2mg tablets (Wyeth Laboratories) true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Sirolimus true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start